Loading...
Interfering with leukemic stem cells
Kinase inhibitors such as imatinib (Gleevec) have improved the outlook for many patients with chronic myeloid leukemia and related blood disorders. But such drugs fail to target the leukemia stem cell population and may not be curative. Krause and Van Etten discuss several clinical studies that sugg...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490184/ https://ncbi.nlm.nih.gov/pubmed/18463658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm0508-494 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|